Schedule 13D ownership disclosure

LAVA THERAPEUTICS NV

Common shares, Euro 0.12 nominal value per share · CUSIP: N51517105

Event date: 2025-10-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Cooperatieve Gilde Healthcare IV U.A.Reported CIK 0001756335

    Shares: 5,246,492 · Class: 19.9%

  • Gilde Healthcare IV Management B.V.Reported CIK 0001757508

    Shares: 5,246,492 · Class: 19.9%

  • Gilde Healthcare Holding B.V.Reported CIK 0001420106

    Shares: 5,246,492 · Class: 19.9%

  • Manapouri B.V.

    Shares: 5,246,492 · Class: 19.9%

  • Martemanshurk B.V.

    Shares: 5,246,492 · Class: 19.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-25-239087
Form type
SCHEDULE 13D/A
Filer
Cooperatieve Gilde Healthcare IV U.A.
CIK
CIK 1756335
Filed
Oct 14, 2025
Reporting period
Oct 09, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub